Cargando…
B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma
The aim of the present study was to analyze features and explore parameters that can help to predict prognosis for angioimmunoblastic T-cell lymphoma (AITL). A total of 117 patients with AITL were retrospectively analyzed. Multivariate analysis showed that β2 microglobulin (β2-M) ≥4.0 mg/L (P = 0.02...
Autores principales: | Shang, Yufeng, Fu, Xiaorui, Chang, Yu, Li, Yanan, Zhang, Mingzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110724/ https://www.ncbi.nlm.nih.gov/pubmed/30150635 http://dx.doi.org/10.1038/s41598-018-31212-z |
Ejemplares similares
-
Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma
por: Huang, Chen, et al.
Publicado: (2020) -
Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T‐cell lymphoma in China
por: Wei, Chong, et al.
Publicado: (2022) -
Inflammation-based Glasgow prognostic score as an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma
por: Chen, Guan-Jun, et al.
Publicado: (2021) -
CUTANEOUS INVOLVEMENT IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
por: Papadavid, Evangelia, et al.
Publicado: (2010) -
Advances in understanding of angioimmunoblastic T-cell lymphoma
por: Chiba, Shigeru, et al.
Publicado: (2020)